A detailed history of Alberta Investment Management Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Alberta Investment Management Corp holds 8,200 shares of UTHR stock, worth $2.97 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,200
Previous 8,200 -0.0%
Holding current value
$2.97 Million
Previous $2.61 Million 12.48%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$228.26 - $319.04 $273,912 - $382,848
-1,200 Reduced 12.77%
8,200 $2.61 Million
Q1 2024

May 14, 2024

BUY
$210.76 - $249.51 $84,304 - $99,804
400 Added 4.44%
9,400 $2.16 Million
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $2.09 Million - $2.45 Million
-9,868 Reduced 52.3%
9,000 $2.03 Million
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $2.02 Million - $2.3 Million
9,868 Added 109.64%
18,868 $4.17 Million
Q1 2023

May 15, 2023

SELL
$212.99 - $276.17 $270,071 - $350,183
-1,268 Reduced 12.35%
9,000 $2.02 Million
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $4.85 Million - $6.6 Million
-23,536 Reduced 69.62%
10,268 $2.86 Million
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $61,707 - $85,122
353 Added 1.06%
33,804 $7.97 Million
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $614,792 - $791,652
-3,700 Reduced 9.96%
33,451 $6 Million
Q4 2021

Feb 11, 2022

BUY
$184.32 - $216.08 $3.6 Million - $4.22 Million
19,551 Added 111.09%
37,151 $8.03 Million
Q3 2021

Nov 15, 2021

SELL
$179.86 - $214.88 $35,972 - $42,976
-200 Reduced 1.12%
17,600 $3.25 Million
Q4 2020

Feb 16, 2021

SELL
$101.87 - $151.79 $1.59 Million - $2.37 Million
-15,600 Reduced 46.71%
17,800 $2.7 Million
Q3 2020

Oct 26, 2020

BUY
$99.9 - $121.13 $949,050 - $1.15 Million
9,500 Added 39.75%
33,400 $3.37 Million
Q2 2020

Aug 11, 2020

BUY
$92.74 - $125.82 $992,318 - $1.35 Million
10,700 Added 81.06%
23,900 $2.89 Million
Q3 2019

Oct 23, 2019

SELL
$74.85 - $85.99 $7,484 - $8,599
-100 Reduced 0.75%
13,200 $1.05 Million
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $1.83 Million - $2.91 Million
-24,100 Reduced 64.44%
13,300 $1.04 Million
Q1 2019

May 15, 2019

BUY
$107.15 - $126.84 $407,170 - $481,992
3,800 Added 11.31%
37,400 $4.39 Million
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $456,300 - $579,285
-4,500 Reduced 11.81%
33,600 $3.66 Million
Q3 2018

Nov 16, 2018

BUY
$113.81 - $129.46 $534,907 - $608,462
4,700 Added 14.07%
38,100 $4.87 Million
Q2 2018

Aug 15, 2018

BUY
$101.14 - $118.31 $536,042 - $627,043
5,300 Added 18.86%
33,400 $3.78 Million
Q1 2018

May 16, 2018

BUY
$107.21 - $151.94 $2.36 Million - $3.34 Million
22,000 Added 360.66%
28,100 $3.16 Million
Q4 2017

Feb 15, 2018

BUY
$118.58 - $151.28 $723,338 - $922,808
6,100
6,100 $902,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.